- Home
- GNLX vs VGI Comparison
GNLX vs VGI Comparison
Compare GNLX & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- VGI
- Stock Information
- Founded
- GNLX 2001
- VGI 2012
- Country
- GNLX United States
- VGI United States
- Employees
- GNLX N/A
- VGI N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- VGI Investment Managers
- Sector
- GNLX Health Care
- VGI Finance
- Exchange
- GNLX Nasdaq
- VGI Nasdaq
- Market Cap
- GNLX 184.4M
- VGI 88.2M
- IPO Year
- GNLX 2023
- VGI N/A
- Fundamental
- Price
- GNLX $3.58
- VGI $7.72
- Analyst Decision
- GNLX Strong Buy
- VGI
- Analyst Count
- GNLX 4
- VGI 0
- Target Price
- GNLX $18.25
- VGI N/A
- AVG Volume (30 Days)
- GNLX 174.5K
- VGI 46.0K
- Earning Date
- GNLX 03-31-2025
- VGI 01-01-0001
- Dividend Yield
- GNLX N/A
- VGI 12.66%
- EPS Growth
- GNLX N/A
- VGI N/A
- EPS
- GNLX N/A
- VGI N/A
- Revenue
- GNLX $8,000.00
- VGI N/A
- Revenue This Year
- GNLX N/A
- VGI N/A
- Revenue Next Year
- GNLX N/A
- VGI N/A
- P/E Ratio
- GNLX N/A
- VGI N/A
- Revenue Growth
- GNLX N/A
- VGI N/A
- 52 Week Low
- GNLX $1.60
- VGI $6.68
- 52 Week High
- GNLX $7.04
- VGI $7.99
- Technical
- Relative Strength Index (RSI)
- GNLX 42.56
- VGI 37.99
- Support Level
- GNLX $3.51
- VGI $7.75
- Resistance Level
- GNLX $4.37
- VGI $7.95
- Average True Range (ATR)
- GNLX 0.44
- VGI 0.07
- MACD
- GNLX -0.13
- VGI -0.02
- Stochastic Oscillator
- GNLX 12.82
- VGI 0.00
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest
Virtus Global Multi-Sector Inc is a United States based fund. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objective by applying extensive credit research to capitalize on opportunities across undervalued areas of the global bond markets.